ASSESSMENT OF THE MARKET FOR BIOLOGICAL PREPARATIONS, INCLUDED IN THE POSITIVE DRUG LIST (PDL), AND THE BUDGETARY IMPACT OF INTRODUCING A NEW PREPARATION

Abstract

The article presented examines the usage, payment, market share and impact on the budget of the National Health Insurance Fund (NHIF), (the perspective of the payer) as well as analysis of pharmacological data, effectiveness and impact on the budget when introducing a new technology for treatment of a group of diseases with biological medicinal products. In the first part of the study, the market for Rituximab (MabThera), Cetrolizumab (Cimzia), Golimumab (Simponi), Tocilizumab (RoActemra), Etanercept (Enbrel), Adalimumab (Humira), Belimumab (Benlysta), Ustekinumab (Stelara), which are included for payment by the NHIF for 2015, has been analyzed. The second part analyzes the introduction of a new technology - Secukinumab (Cosentyx) – (ATC code - L04AC10), and the budgetary impact on the payer.

Authors and Affiliations

Petko Salchev, Tony Vekov

Keywords

Related Articles

TRENDS IN THE INTERNET USE FOR HEALTH-RELATED INFORMATION AMONG THE BULGARIAN POPULATION AGED 20 AND OVER

Globally there has been a steady increase in consumers seeking health information on the Internet. A good knowledge of Internet audiences is an important factor in the effective use of this health communication channel....

REGIONAL DIFFERENCES AND HEALTH RISKS. Comparative analysis by regions and periods of 2014 and 2016

One of the main challenges for health policy makers is analyzing available information, assessing risks arising at specified times, and taking evidence-based decisions. This is a particularly difficult process in healthc...

FOOD AND NUTRITION ACTION PLAN OF BULGARIA, 2005-2010: ACHIEVEMENTS AND CHALLENGES

The national Food and Nutrition Action Plan, 2005- 2010, for Bulgaria includes three main aspects: nutrition, food safety and sustainable food supply. This publication presents the implemented works, achievements and cha...

NON-SPECIFIC IMMUNE REACTIVITY OF WORKERS EXPOSED TO CARBON DISULFIDE

The aim of the study is to assess the non-specific immune reactivity of workers from viscose rayon production, exposed to carbon disulfide (CS2 ), with respect to the level of exposure. Materials and methods: This study...

RESEARCH OF THE CITIZENS’ATTITUDE IN THEIR USE OF PLANT FOOD SUPPLEMENTS IN BULGARIA

This publication presents the results of a research into consumers’ attitudes towards the use of teas. Materials and methods: A cross-sectional survey design with 400 individuals aged 18-80, who expressed willingness and...

Download PDF file
  • EP ID EP554305
  • DOI -
  • Views 45
  • Downloads 0

How To Cite

Petko Salchev, Tony Vekov (2019). ASSESSMENT OF THE MARKET FOR BIOLOGICAL PREPARATIONS, INCLUDED IN THE POSITIVE DRUG LIST (PDL), AND THE BUDGETARY IMPACT OF INTRODUCING A NEW PREPARATION. Българско списание за обществено здраве (Bulgarian Journal of Public Health), 0(1), 3-45. https://europub.co.uk/articles/-A-554305